Clinical Trial Update: A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the effect of Aldurazyme (Laronidase) on lactation in female patients with MPS I and their breastfed infants; study terminated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis

Drugs mentioned

• Aldurazyme (Laronidase)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Mucopolysaccharidosis I, Hurler's Syndrome | Phase 4 | Status: TERMINATED | Results posted: 2024-02-20